They often sport cryptic patterns—earthy tones of brown, grey, and black—interspersed with translucent "hyaline" spots. These spots look like tiny windows in the wing, a common feature in the skipper family used to break up their silhouette against predators.
As of March 2025, Cerbios-Pharma SA became part of the , a move aimed at creating a leading international group in the CDMO sector, backed by 65 Equity Partners. Core Competencies and Specialized Divisions cerbiosini
Based in Switzerland, Cerbios operates out of facilities in Barbengo-Lugano and Couvet. These production sites are regularly inspected by major regulatory agencies, including: FDA (Food and Drug Administration) They often sport cryptic patterns—earthy tones of brown,
Long before the global wellness market focused on the gut microbiome, Cerbios was manufacturing pharmaceutical-grade probiotics. Their proprietary strain, Enterococcus lactis SF68® (formerly E. faecium ), has been produced to a cGMP pharmaceutical grade since 1978. Supported by dozens of published clinical trials, this specific biological agent is a globally recognized drug product used to treat: faecium ), has been produced to a cGMP